141 related articles for article (PubMed ID: 17559684)
1. PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison.
Rothschild S; Studer G; Seifert B; Huguenin P; Glanzmann C; Davis JB; Lütolf UM; Hany TF; Ciernik IF
Radiat Oncol; 2007 Jun; 2():22. PubMed ID: 17559684
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers.
Matsuura T; Nishimura Y; Nakamatsu K; Kanamori S; Ishikawa K; Tachibana I; Hosono M; Shibata T
Int J Clin Oncol; 2017 Feb; 22(1):52-58. PubMed ID: 27604973
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer.
Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutic S; Mutch DG; Powell MA; Grigsby PW
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1085-91. PubMed ID: 19880262
[TBL] [Abstract][Full Text] [Related]
4. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
5. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
[TBL] [Abstract][Full Text] [Related]
6. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
7. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.
Wang D; Schultz CJ; Jursinic PA; Bialkowski M; Zhu XR; Brown WD; Rand SD; Michel MA; Campbell BH; Wong S; Li XA; Wilson JF
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):143-51. PubMed ID: 16618577
[TBL] [Abstract][Full Text] [Related]
8. Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
Katahira-Suzuki R; Hata M; Tateishi U; Taguchi T; Takano S; Omura-Minamisawa M; Inoue T
Ann Nucl Med; 2015 Jan; 29(1):37-45. PubMed ID: 25228378
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography-computed tomography before treatment is highly prognostic of distant metastasis in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy treatment: a prospective study with long-term follow-up.
Xiao W; Xu A; Han F; Lin X; Lu L; Shen G; Huang S; Fan W; Deng X; Zhao C
Oral Oncol; 2015 Apr; 51(4):363-9. PubMed ID: 25655559
[TBL] [Abstract][Full Text] [Related]
11. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
12. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
13. PET/CT scanning guided intensity-modulated radiotherapy in treatment of recurrent ovarian cancer.
Du XL; Jiang T; Sheng XG; Li QS; Wang C; Yu H
Eur J Radiol; 2012 Nov; 81(11):3551-6. PubMed ID: 22521528
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
[TBL] [Abstract][Full Text] [Related]
15. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.
Lee NY; de Arruda FF; Puri DR; Wolden SL; Narayana A; Mechalakos J; Venkatraman ES; Kraus D; Shaha A; Shah JP; Pfister DG; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):966-74. PubMed ID: 17145527
[TBL] [Abstract][Full Text] [Related]
16. A prospective dosimetric and clinical comparison of acute hematological toxicities in three-dimensional conformal radiation therapy and intensity modulated radiation therapy with concurrent chemotherapy in carcinoma cervix.
Avinash HU; Arul Ponni TR; Janaki MG; Kirthi Koushik AS; Kumar SM
J Cancer Res Ther; 2015; 11(1):83-7. PubMed ID: 25879342
[TBL] [Abstract][Full Text] [Related]
17. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
[TBL] [Abstract][Full Text] [Related]
18. Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors.
Simeonova A; Abo-Madyan Y; El-Haddad M; Welzel G; Polednik M; Boggula R; Wenz F; Lohr F
Radiother Oncol; 2012 Feb; 102(2):268-73. PubMed ID: 22100654
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
20. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer.
Freilich J; Hoffe SE; Almhanna K; Dinwoodie W; Yue B; Fulp W; Meredith KL; Shridhar R
Dis Esophagus; 2015; 28(4):352-7. PubMed ID: 24635657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
